Financials King International Investment Limited
Equities
928
KYG5924H1231
Healthcare Facilities & Services
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 HKD | 0.00% | +3.90% | -2.44% |
03-19 | King International Investment Limited Announces Management Changes | CI |
03-14 | King International Investment Limited Announces Change of Joint Company Secretary Andauthorised Representative | CI |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 1,252 | 299.8 | 160.6 | 282.7 | 155.5 | 146.5 |
Enterprise Value (EV) 1 | 1,201 | 278.8 | -25.07 | 274.8 | 118.5 | 135.4 |
P/E ratio | -12.8 x | -2.51 x | -6.46 x | -57.8 x | -4.51 x | -5.56 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 19.9 x | 4.72 x | 2.52 x | 2.77 x | 1.67 x | 0.65 x |
EV / Revenue | 19.1 x | 4.39 x | -0.39 x | 2.69 x | 1.28 x | 0.61 x |
EV / EBITDA | -15.6 x | -2.29 x | 1.43 x | 74.7 x | -3.84 x | -4.54 x |
EV / FCF | -6.06 x | -5.86 x | -0.14 x | -1.45 x | 1.41 x | -1.38 x |
FCF Yield | -16.5% | -17.1% | -704% | -69% | 70.8% | -72.4% |
Price to Book | 3.14 x | 1.04 x | 0.65 x | 0.97 x | 0.59 x | 0.62 x |
Nbr of stocks (in thousands) | 1,051,725 | 1,070,857 | 1,070,857 | 1,285,025 | 1,285,025 | 1,542,025 |
Reference price 2 | 1.190 | 0.2800 | 0.1500 | 0.2200 | 0.1210 | 0.0950 |
Announcement Date | 16/07/18 | 30/09/19 | 17/07/20 | 30/07/21 | 09/09/22 | 28/07/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 62.79 | 63.49 | 63.8 | 102 | 92.87 | 223.9 |
EBITDA 1 | -77.22 | -121.8 | -17.55 | 3.68 | -30.89 | -29.84 |
EBIT 1 | -83.9 | -128.9 | -19.86 | 2.753 | -31.66 | -32.52 |
Operating Margin | -133.62% | -203.04% | -31.13% | 2.7% | -34.09% | -14.53% |
Earnings before Tax (EBT) 1 | -93.45 | -120.9 | -23.42 | 0.641 | -36.69 | -30.71 |
Net income 1 | -94.24 | -118.9 | -24.85 | -4.583 | -34.46 | -25.19 |
Net margin | -150.09% | -187.21% | -38.95% | -4.49% | -37.1% | -11.25% |
EPS 2 | -0.0933 | -0.1115 | -0.0232 | -0.003806 | -0.0268 | -0.0171 |
Free Cash Flow 1 | -198.3 | -47.61 | 176.5 | -189.6 | 83.91 | -98.06 |
FCF margin | -315.78% | -75% | 276.68% | -185.8% | 90.35% | -43.81% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 16/07/18 | 30/09/19 | 17/07/20 | 30/07/21 | 09/09/22 | 28/07/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 50.5 | 21.1 | 186 | 7.86 | 37 | 11.1 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -198 | -47.6 | 177 | -190 | 83.9 | -98.1 |
ROE (net income / shareholders' equity) | -24.2% | -35.4% | -8.82% | -0.86% | -13.4% | -12.8% |
ROA (Net income/ Total Assets) | -12.9% | -22.3% | -4.11% | 0.55% | -6.3% | -7.17% |
Assets 1 | 729.1 | 531.8 | 605.2 | -837.7 | 546.7 | 351.5 |
Book Value Per Share 2 | 0.3800 | 0.2700 | 0.2300 | 0.2300 | 0.2000 | 0.1500 |
Cash Flow per Share 2 | 0.0300 | 0.0200 | 0.1800 | 0.0100 | 0.0300 | 0.0100 |
Capex 1 | 12.6 | 1.52 | - | - | 0.01 | 0.21 |
Capex / Sales | 20.13% | 2.4% | - | - | 0.01% | 0.1% |
Announcement Date | 16/07/18 | 30/09/19 | 17/07/20 | 30/07/21 | 09/09/22 | 28/07/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-2.44% | 18.94M | |
+14.31% | 81.04B | |
-30.46% | 68.93B | |
+11.55% | 29.59B | |
+1.46% | 17.24B | |
-11.30% | 16.99B | |
-1.26% | 15.12B | |
+2.64% | 13.09B | |
+62.55% | 12B | |
+29.68% | 11.91B |
- Stock Market
- Equities
- 928 Stock
- Financials King International Investment Limited